Salesforce
CRM
Microsoft
MSFT
Apple
AAPL
Coinbase
COIN
MARA Holdings
MARA
US Stock MarketDetailed Quotes
TNFA TNF Pharmaceuticals
- 1.186
- -0.034-2.80%
Trading Dec 12 13:59 ET
3.27MMarket Cap-0.09P/E (TTM)
1.288High1.170Low92.51KVolume1.200Open1.220Pre Close112.58KTurnover3.88%Turnover RatioLossP/E (Static)2.76MShares10.66552wk High0.20P/B2.83MFloat Cap1.07052wk Low--Dividend TTM2.39MShs Float6469632.000Historical High--Div YieldTTM9.66%Amplitude1.070Historical Low1.216Avg Price1Lot Size
TNF Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -15.05%-3.63M | 31.92%-2.67M | 51.86%-1.91M | -5.79%-12.98M | 14.04%-1.93M | 22.78%-3.16M | -9.86%-3.92M | -67.85%-3.97M | 37.13%-12.27M | 53.28%-2.25M |
| Net income from continuing operations | -147.72%-1.93M | -129.52%-9.57M | -548.27%-9.8M | 73.68%-4M | 36.90%-2.36M | 209.46%4.04M | -14.62%-4.17M | 63.33%-1.51M | 49.15%-15.2M | -15.61%-3.75M |
| Operating gains losses | 105.68%438.2K | -159.27%-2.28M | 766.95%7.03M | -215,479.21%-12.85M | -286,906.01%-3.2M | -642,763.92%-7.71M | -44,166.38%-880.89K | -64,007.58%-1.05M | -99.96%5.96K | 299.46%1.12K |
| Other non cash items | --9.87K | -73.96%24.32K | -40.48%29.26K | ---- | ---- | --0 | 1,800.02%93.41K | 207.29%49.16K | ---- | ---- |
| Change In working capital | -1,706.89%-2.08M | 2,394.65%240.36K | 122.82%336.91K | -63.41%815.52K | 55.56%2.15M | 117.40%129.68K | 115.22%9.64K | -189.25%-1.48M | 143.02%2.23M | 188.37%1.38M |
| -Change in prepaid assets | -137.15%-93.72K | 27.19%-566.22K | 197.51%168.07K | -160.57%-327.44K | -13.36%370.25K | -33.31%252.28K | -59.58%-777.62K | -177.56%-172.35K | 159.22%540.56K | 180.59%427.34K |
| -Change in payables and accrued expense | -1,252.27%-1.66M | -4.06%755.28K | 99.25%-9.83K | -38.16%1.04M | 76.00%1.68M | 89.09%-122.61K | 85.93%787.25K | -191.10%-1.3M | 139.51%1.69M | 192.37%955.91K |
| -Change in other current liabilities | ---- | ---- | -357.32%-404 | ---- | ---- | ---- | ---- | --157 | ---- | ---- |
| -Change in other working capital | -5,533,300.00%-331.99K | --50.9K | --179.08K | 5,114.40%99.96K | 23,603.56%99.79K | -98.92%6 | ---- | ---- | 2,466.67%1.92K | 178.40%421 |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -15.05%-3.63M | 31.92%-2.67M | 51.86%-1.91M | -5.79%-12.98M | 14.04%-1.93M | 22.78%-3.16M | -9.86%-3.92M | -67.85%-3.97M | 37.13%-12.27M | 53.28%-2.25M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -8.18%3.09M | -388.12%-11.02M | 106.49%732.02K | -73.30%1.85M | 120.80%5.93M | 248.20%3.36M | 9.48%3.83M | -475.89%-11.27M | -65.17%6.91M | -10.37%2.69M |
| Net investment purchase and sale | -8.18%3.09M | -388.12%-11.02M | 106.49%732.02K | -73.30%1.85M | 120.80%5.93M | 248.20%3.36M | 9.48%3.83M | -475.89%-11.27M | -62.57%6.91M | -10.37%2.69M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -8.18%3.09M | -388.12%-11.02M | 106.49%732.02K | -73.30%1.85M | 120.80%5.93M | 248.20%3.36M | 9.48%3.83M | -475.89%-11.27M | -65.17%6.91M | -10.37%2.69M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 1.2M | 14M | -108.68%-1.28M | 135.44%13.07M | -1.62M | 0 | 0 | 14.69M | 7,447.67%5.55M | 0 |
| Net common stock issuance | ---- | ---- | --0 | --0 | ---- | ---- | ---- | --14.69M | --5.55M | --0 |
| Net preferred stock issuance | --68.1K | -4.67%14M | ---141.58K | --14.52M | ---166.73K | --0 | --14.69M | --0 | --0 | --0 |
| Cash dividends paid | ---- | --0 | ---1.13M | ---1.45M | ---- | ---- | --0 | --0 | --0 | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --1.2M | --14M | -108.68%-1.28M | 135.44%13.07M | ---1.62M | --0 | --0 | --14.69M | 7,447.67%5.55M | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | 471.32%536.03K | 19.68%225.66K | 257.90%2.68M | 34.74%749.09K | -3.75%298.32K | -91.59%93.82K | -84.15%188.55K | 34.74%749.09K | 274.93%555.97K | -77.46%309.93K |
| Current changes in cash | 220.95%656.33K | 427.65%310.37K | -338.03%-2.46M | 900.36%1.93M | 442.55%2.38M | 125.38%204.5K | -28.62%-94.73K | -188.52%-560.54K | -52.63%193.12K | 153.62%439.16K |
| End cash Position | 299.69%1.19M | 471.32%536.03K | 19.68%225.66K | 257.90%2.68M | 257.90%2.68M | -3.75%298.32K | -91.59%93.82K | -84.15%188.55K | 34.74%749.09K | 34.74%749.09K |
| Free cash flow | -15.05%-3.63M | 31.92%-2.67M | 51.86%-1.91M | -5.79%-12.98M | 14.04%-1.93M | 22.78%-3.16M | -9.86%-3.92M | -67.85%-3.97M | 37.13%-12.27M | 53.28%-2.25M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.